表紙
市場調查報告書

乾癬治療藥的全球市場

Global Market Study on Psoriasis Drugs: Topical Products Segment Anticipated to be the Most Attractive During 2018 - 2028

出版商 Persistence Market Research 商品編碼 746672
出版日期 內容資訊 英文 243 Pages
商品交期: 2-3個工作天內
價格
Back to Top
乾癬治療藥的全球市場 Global Market Study on Psoriasis Drugs: Topical Products Segment Anticipated to be the Most Attractive During 2018 - 2028
出版日期: 2018年10月25日內容資訊: 英文 243 Pages
簡介

本報告提供全球乾癬治療藥市場相關調查,市場概要與地區及各市場區隔趨勢,加入此市場的主要企業的簡介等資料彙整。

目錄

第1章 摘要整理

第2章 市場相關資料

  • 市場分類
  • 市場定義
  • 除外及對象

第3章 市場機會分析

  • 宏觀經濟要素
  • 市場機會分析

第4章 市場背景

  • 乾癬的藥物治療市場演進
  • 市場趨勢
    • 成長要素
    • 阻礙因素
    • 趨勢

第5章 宏觀經濟前提

第6章 世界經濟預測

  • 國內生產總值:各地區以及各國
  • 全球皮膚科學市場指標

第7章 主要內容

  • 病的流行病學
  • 技術評估與趨勢
  • 法規方案

第8章 北美市場分析及預測

  • 簡介
  • 過去的市場分析:各國
    • 美國
    • 加拿大
  • 市場預測:各國
  • 過去的市場趨勢分析:各產品類型
    • 局部用藥物
    • 口服藥
    • 注射劑
  • 市場及預測:各產品類型
  • 過去的市場趨勢分析:各藥物等級
    • 白細胞介素抑制劑
    • 皮質類固醇
    • 抗發炎
    • 腫瘤壞死因子抑制劑
  • 市場預測:各藥物等級
  • 過去的市場趨勢分析:各症狀
    • 斑塊型乾癬
    • 指甲乾癬
    • 水滴狀乾癬
    • 膿皰型乾癬
    • 紅皮型乾癬
  • 市場預測:疾病終期的各症狀
  • 過去的市場趨勢分析:各流通管道
    • 醫院藥局
    • 零售藥局
    • 電子商務
  • 市場預測:各流通管道
  • 市場魅力分析
    • 各國
    • 各產品類型
    • 各藥物等級
    • 病的各症狀
    • 各銷售管道
  • 成長要素及阻礙因素:影響分析
  • 主要市場參與者 - 強度製圖
  • 主要合併及收購

第9章 南美市場分析及預測

  • 簡介
  • 過去的市場分析:各國
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 市場預測:各國
  • 過去的市場趨勢分析:各產品類型
    • 局部用藥物
    • 口服藥
    • 注射劑
  • 市場及預測:各產品類型
  • 過去的市場趨勢分析:各藥物等級
    • 白細胞介素抑制劑
    • 皮質類固醇
    • 抗發炎
    • 腫瘤壞死因子抑制劑
  • 市場預測:各藥物等級
  • 過去的市場趨勢分析:各症狀
    • 斑塊型乾癬
    • 指甲乾癬
    • 水滴狀乾癬
    • 膿皰型乾癬
    • 紅皮型乾癬
  • 市場預測:疾病終期的各症狀
  • 過去的市場趨勢分析:各流通管道
    • 醫院藥局
    • 零售藥局
    • 電子商務
  • 市場預測:各流通管道
  • 市場魅力分析
    • 各國
    • 各產品類型
    • 各藥物等級
    • 疾病的各症狀
    • 各銷售管道
  • 成長要素及阻礙因素:影響分析
  • 主要市場參與者 - 強度製圖
  • 主要合併及收購

第10章 歐洲市場分析與預測

  • 簡介
  • 過去的市場分析:各國
    • EU-4
    • 英國
    • 荷比盧三國
    • 其他的西歐地區
  • 市場預測:各國
  • 過去的市場趨勢分析:各產品類型
    • 局部用藥物
    • 口服藥
    • 注射劑
  • 市場及預測:各產品類型
  • 過去的市場趨勢分析:各藥物等級
    • 白細胞介素抑制劑
    • 皮質類固醇
    • 抗發炎
    • 腫瘤壞死因子抑制劑
  • 市場預測:各藥物等級
  • 過去的市場趨勢分析:各症狀
    • 斑塊型乾癬
    • 指甲乾癬
    • 水滴狀乾癬
    • 膿皰型乾癬
    • 紅皮型乾癬
  • 市場預測:疾病終期的各症狀
  • 過去的市場趨勢分析:各流通管道
    • 醫院藥局
    • 零售藥局
    • 電子商務
  • 市場預測:各流通管道
  • 市場魅力分析
    • 各國
    • 各產品類型
    • 各藥物等級
    • 疾病的各症狀
    • 各銷售管道
  • 成長要素及阻礙因素:影響分析
  • 主要市場參與者 - 強度製圖
  • 主要合併及收購

第12章 中國和日本以外亞太地區市場分析與預測

  • 簡介
  • 過去的市場分析:各國
    • 印度
    • 澳洲和紐西蘭
    • ASEAN
    • 其他APECJ各國
  • 市場預測:各國
  • 過去的市場趨勢分析:各產品類型
    • 局部用藥物
    • 口服藥
    • 注射劑
  • 市場及預測:各產品類型
  • 過去的市場趨勢分析:各藥物等級
    • 白細胞介素抑制劑
    • 皮質類固醇
    • 抗發炎
    • 腫瘤壞死因子抑制劑
  • 市場預測:各藥物等級
  • 過去的市場趨勢分析:各症狀
    • 斑塊型乾癬
    • 指甲乾癬
    • 水滴狀乾癬
    • 膿皰型乾癬
    • 紅皮型乾癬
  • 市場預測:疾病終期的各症狀
  • 過去的市場趨勢分析:各流通管道
    • 醫院藥局
    • 零售藥局
    • 電子商務
  • 市場預測:各流通管道
  • 市場魅力分析
    • 各國
    • 各產品類型
    • 各藥物等級
    • 疾病的各症狀
    • 各銷售管道
  • 成長要素及阻礙因素:影響分析
  • 主要市場參與者 - 強度製圖
  • 主要合併及收購

第13章 CIS和俄羅斯市場分析與預測

  • 簡介
  • 過去的市場趨勢分析:各產品類型
    • 局部用藥物
    • 口服藥
    • 注射劑
  • 市場及預測:各產品類型
  • 過去的市場趨勢分析:各藥物等級
    • 白細胞介素抑制劑
    • 皮質類固醇
    • 抗發炎
    • 腫瘤壞死因子抑制劑
  • 市場預測:各藥物等級
  • 過去的市場趨勢分析:各症狀
    • 斑塊型乾癬
    • 指甲乾癬
    • 水滴狀乾癬
    • 膿皰型乾癬
    • 紅皮型乾癬
  • 市場預測:疾病終期的各症狀
  • 過去的市場趨勢分析:各流通管道
    • 醫院藥局
    • 零售藥局
    • 電子商務
  • 市場預測:各流通管道
  • 市場魅力分析
    • 各國
    • 各產品類型
    • 各藥物等級
    • 疾病的各症狀
    • 各銷售管道
  • 成長要素及阻礙因素:影響分析
  • 主要市場參與者 - 強度製圖
  • 主要合併及收購

第14章 日本市場分析與預測

  • 簡介
  • 過去的市場趨勢分析:各產品類型
    • 局部用藥物
    • 口服藥
    • 注射劑
  • 市場及預測:各產品類型
  • 過去的市場趨勢分析:各藥物等級
    • 白細胞介素抑制劑
    • 皮質類固醇
    • 抗發炎
    • 腫瘤壞死因子抑制劑
  • 市場預測:各藥物等級
  • 過去的市場趨勢分析:各症狀
    • 斑塊型乾癬
    • 指甲乾癬
    • 水滴狀乾癬
    • 膿皰型乾癬
    • 紅皮型乾癬
  • 市場預測:疾病終期的各症狀
  • 過去的市場趨勢分析:各流通管道
    • 醫院藥局
    • 零售藥局
    • 電子商務
  • 市場預測:各流通管道
  • 市場魅力分析
    • 各國
    • 各產品類型
    • 各藥物等級
    • 疾病的各症狀
    • 各銷售管道
  • 成長要素及阻礙因素:影響分析
  • 主要市場參與者 - 強度製圖
  • 主要合併及收購

第15章 中東、非洲市場分析及預測

  • 簡介
  • 過去的市場分析:各國
    • GCC各國
    • 南非
    • 其他
  • 市場預測:各國
  • 過去的市場趨勢分析:各產品類型
    • 局部用藥物
    • 口服藥
    • 注射劑
  • 市場及預測:各產品類型
  • 過去的市場趨勢分析:各藥物等級
    • 白細胞介素抑制劑
    • 皮質類固醇
    • 抗發炎
    • 腫瘤壞死因子抑制劑
  • 市場預測:各藥物等級
  • 過去的市場趨勢分析:各症狀
    • 斑塊型乾癬
    • 指甲乾癬
    • 水滴狀乾癬
    • 膿皰型乾癬
    • 紅皮型乾癬
  • 市場預測:疾病終期的各症狀
  • 過去的市場趨勢分析:各流通管道
    • 醫院藥局
    • 零售藥局
    • 電子商務
  • 市場預測:各流通管道
  • 市場魅力分析
    • 各國
    • 各產品類型
    • 各藥物等級
    • 疾病的各症狀
    • 各銷售管道
  • 成長要素及阻礙因素:影響分析
  • 主要市場參與者 - 強度製圖
  • 主要合併及收購

第16章 預測要素:相關性及影響

第17章 預測的假設

第18章 市場結構分析

  • 市場結構:各企業層
  • 市場佔有率分析(%)(2017年)
  • 品牌佔有率分析(%):各主要產品

第19章 競爭分析

  • 競爭儀表板
  • 競爭的基準
  • 深度分析
    • Janssen Biotech,Inc.
    • Novartis International Ltd.
    • Amgen Inc.
    • Pfizer Inc.
    • Takeda Pharmaceutical Company Ltd.
    • Merck & Co, Inc.
    • Abb Vie Inc.
    • Eli Lilly and Company
    • Boehringer Ingelheim GmbH
    • Sun Pharmaceutical Industries Ltd

第20章 市場分析及預測:各地區

  • 簡介/主要的觀察
  • 過去的市場分析:各地區
    • 北美
    • 中南美
    • 歐洲
    • 日本以外亞太地區
    • 日本
    • CIS和俄羅斯
    • 中東、非洲
  • 市場預測:各地區
  • 市場魅力分析:各地區

第21章 市場分析及預測:各產品類型

  • 簡介/主要的發現
  • 過去的市場與分析:各產品類型
    • 局部用藥物
    • 口服藥
    • 注射劑
  • 市場及預測:各產品的類型
  • 市場魅力分析:各產品類型

第22章 市場分析及預測:各藥物等級

  • 簡介/主要的發現
  • 過去的市場分析:各藥物等級
    • 白細胞介素抑制劑
    • 皮質類固醇
    • 抗發炎
    • 腫瘤壞死因子抑制劑
  • 市場預測:各藥物等級
  • 市場魅力分析:各藥物等級

第23章 市場分析與預測:疾病的各症狀

  • 簡介/主要的發現
  • 過去的市場分析:各症狀
    • 斑塊型乾癬
    • 指甲乾癬
    • 水滴狀乾癬
    • 膿皰型乾癬
    • 紅皮型乾癬
  • 市場預測:各症狀
  • 市場魅力分析:各症狀

第24章 市場分析及預測:各流通管道

  • 簡介/主要的發現
  • 過去的市場分析:各流通管道
    • 醫院藥局
    • 零售藥局
    • 電子商務
  • 市場預測:各流通管道

第25章 市場分析及預測

  • 市場價值分析:全各市場區隔
  • YoY成長分析:全各市場區隔

第26章 使用首字母和縮寫

第27章 調查方法

目錄

A recent market study published by the company - "Psoriasis Drug Treatment Market: Global Industry Analysis 2013-2017 & Forecast 2018-2028" consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the Psoriasis Drug Treatment market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the Psoriasis Drug Treatment market during the forecast period. It can help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the Psoriasis Drug Treatment market in the upcoming years. The report provides detailed information about the current and future growth prospects of the Psoriasis Drug Treatment market in the most comprehensive way for the better understanding of readers.

Chapter 1 - Executive Summary

The report commences with the executive summary of the Psoriasis Drug Treatment market report, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the Psoriasis Drug Treatment market.

Chapter 2 - Market Overview

Readers can find detailed taxonomy and the definition of the Psoriasis Drug Treatment market in this chapter, which helps readers to understand the basic information about the Psoriasis Drug Treatment market dynamics, Regulatory Scenarios, Pipeline assessment, Reimbursement Scenarios list of key market participants included in the report.

Chapter 3 - Global Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028), By Product Type

Based on the product type, the Psoriasis Drug Treatment market is segmented into topical psoriasis drug, oral psoriasis drug and injectable psoriasis drug. In this chapter, readers can find information about key trends and developments in the Psoriasis Drug Treatment market and market attractive analysis based on the type of Psoriasis Treatment Products. In this chapter, readers can find information about key trends and developments in the Psoriasis Drug Treatment market and market attractive analysis based on the product type for each region.

Chapter 4 - Global Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028), By Drug Class

Based on the Drug Class, the psoriasis drug treatment market is segmented into Corticosteroids, Anti-inflammatory, Interleukin Inhibitors and Tumor Necrosis Factor Inhibitors. In this chapter, readers can find information about key trends and developments in the psoriasis drug treatment market and market attractive analysis based on drug class. In this chapter, readers can find information about key trends and developments in the psoriasis drug treatment market and market attractive analysis based on the drug class for each region.

Chapter 5 - Global Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028), By Disease Indication

Based on the Disease Indication, the psoriasis drug treatment market is segmented into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erythrodermic psoriasis. In this chapter, readers can find information about key trends and developments in the psoriasis drug treatment market and market attractive analysis based on disease indication type. In this chapter, readers can find information about key trends and developments in the psoriasis drug treatment market and market attractive analysis based on the disease indication type for each region.

Chapter 6 - Global Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028), By Distribution Channel

Based on the Distribution Channel, the psoriasis drug treatment market is segmented into hospital pharmacies, retail pharmacies and E-commerce. In this chapter, readers can find information about key trends and developments in the psoriasis drug market and market attractive analysis based on distribution channel. In this chapter, readers can find information about key trends and developments in the psoriasis drug treatment market and market attractive analysis based on the distribution channel for each region.

Chapter 7 - Global Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028), By Region

This chapter explains how the Psoriasis Drug Treatment market will grow across various geographic regions, such as North America, Latin America, Europe, CIS & Russia Asia-Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA).

Chapter 8 - North America Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028)

This chapter includes detailed analysis of the growth of the North America Psoriasis Drug Treatment market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on product type, drug class type, disease indication type, distribution channel and country of psoriasis drug treatment in the North American region.

Chapter 9 - Latin America Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028)

Readers can find detailed information about factors such as, pricing analysis, and regional trends that are impacting the growth of the Latin America Psoriasis Drug Treatment market. This chapter also includes the growth prospects of the Psoriasis Drug Treatment market in leading LATAM countries such as Brazil, Mexico and rest of the Latin America region.

Chapter 10 - Europe Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028)

Important growth prospects of the Psoriasis Drug Treatment market based on its product types, form, and applications in several European countries, such as EU4, UK, BENELUX, Nordic, and Rest of Europe is included in this chapter.

Chapter 11 - CIS & Russia Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028)

Readers can find important factors that can make a huge impact on the growth of the Psoriasis Drug Treatment market in CIS & Russia based on the market segmentation, during the forecast period. This chapter provides the overview of regulations, drivers, restraints, and trends in the CIS & Russia Psoriasis Drug Treatment market.

Chapter 12 - APEJ Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028)

Great China, India, ASEAN, Australia and New Zealand are the leading countries in the APEJ region that are the prime subject of assessment to obtain growth prospects of the APEJ Psoriasis Drug Treatment market in this chapter. Readers can find thorough information about the growth parameters of the APEJ psoriasis drug treatment market during the period 2016-2022.

Chapter 13 - Japan Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028)

Readers can find important factors that can make a huge impact on the growth of the Psoriasis Drug Treatment market in Japan based on the market segmentation, during the forecast period. This chapter provides the overview of regulations, drivers, restraints, and trends in the Japan Psoriasis Drug Treatment market.

Chapter 14 - MEA Psoriasis Drug Treatment Market Analysis (2013-2017) & Forecast (2018-2028)

This chapter provides information on how the Psoriasis Drug Treatment market will grow in the major countries in MEA region, such as GCC Countries, Turkey, Iran, Israel, and South Africa, during the period 2013-2028.

Chapter 15 - Competition Landscape, Company Share and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Psoriasis Drug Treatment market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Market players featured in the report include Merck & Co, Inc., Amgen Inc., Pfizer Inc., Janssen Biotech Inc., Novartis International Ltd, Abb Vie Inc., Sun Pharmaceutical Industries LTD., Eli Lilly & Company, Boehringer Ingelheim GmbH.

Chapter 16 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 17 - Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the Psoriasis Drug Treatment market.

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. FMI Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition
  • 2.3. Exclusion and Inclusion

3. Psoriasis Drug Treatment Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis

4. Market Background

  • 4.1. Psoriasis Drug Treatment Market Evolution
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
      • 4.2.1.1. Supply Side Drivers
      • 4.2.1.2. Demand Side Drivers
    • 4.2.2. Restraints
    • 4.2.3. Trends

5. Macroeconomic Assumptions

6. Global Economic Outlook

  • 6.1. Gross Domestic Product by Region & Country, 2016 - 2021
  • 6.2. Global Dermatology Market Indicators

7. Key Inclusions

  • 7.1. Disease Epidemiology
  • 7.2. Technology Assessment & Trends
  • 7.4. Regulatory Scenario

8. North America Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2017
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
  • 8.4. Historical Market Size (US$ Mn) Trend Analysis by Product Type, 2013-2017
    • 8.4.1. Topical
    • 8.4.2. Oral
    • 8.4.3. Injectable
  • 8.5. Market Size (US$ Mn) & Forecast By Product Type, 2018-2028
  • 8.6. Historical Market Size (US$ Mn) Trend Analysis by Drug Class, 2013-2017
    • 8.6.1. Interleukin Inhibitors
    • 8.6.2. Corticosteroids
    • 8.6.3. Anti-inflammatory
    • 8.6.4. Tumor Necrosis Factor Inhibitor
  • 8.7. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
  • 8.8. Historical Market Size (US$ Mn) Trend Analysis by Disease Indication, 2013-2017
    • 8.8.1. Plaque Psoriasis
    • 8.8.2. Nail Psoriasis
    • 8.8.3. Guttate Psoriasis
    • 8.8.4. Pustular Psoriasis
    • 8.8.5. Erythrodermic Psoriasis
  • 8.9. Market Size (US$ Mn) Forecast By End Disease Indication, 2018-2028
  • 8.10. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2017
    • 8.10.1. Hospital Pharmacies
    • 8.10.2. Retail Pharmacies
    • 8.10.3. E-Commerce
  • 8.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
  • 8.12. Market Attractiveness Analysis
    • 8.12.1. By Country
    • 8.12.2. By Product Type
    • 8.12.3. By Drug Class
    • 8.12.4. By Disease Indication
    • 8.12.5. Distribution Channel
  • 8.13. Drivers and Restraints: Impact Analysis
  • 8.14. Key Market Participants - Intensity Mapping
  • 8.15. Key Mergers & Acquisitions

9. Latin America Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2017
    • 9.2.1. Brazil
    • 9.2.2. Mexico
    • 9.2.3. Argentina
    • 9.2.4. Rest of Latin America
  • 9.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
  • 9.4. Historical Market Size (US$ Mn) Trend Analysis by Product Type, 2013-2017
    • 9.4.1. Topical
    • 9.4.2. Oral
    • 9.4.3. Injectable
  • 9.5. Market Size (US$ Mn) & Forecast By Product Type, 2018-2028
  • 9.6. Historical Market Size (US$ Mn) Trend Analysis by Drug Class, 2013-2017
    • 9.6.1. Interleukin Inhibitors
    • 9.6.2. Corticosteroids
    • 9.6.3. Anti-inflammatory
    • 9.6.4. Tumor Necrosis Factor Inhibitor
  • 9.7. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
  • 9.8. Historical Market Size (US$ Mn) Trend Analysis by Disease Indication, 2013-2017
    • 9.8.1. Plaque Psoriasis
    • 9.8.2. Nail Psoriasis
    • 9.8.3. Guttate Psoriasis
    • 9.8.4. Pustular Psoriasis
    • 9.8.5. Erythrodermic Psoriasis
  • 9.9. Market Size (US$ Mn) Forecast By End Disease Indication, 2018-2028
  • 9.10. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2017
    • 9.10.1. Hospital Pharmacies
    • 9.10.2. Retail Pharmacies
    • 9.10.3. E-Commerce
  • 9.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
  • 9.12. Market Attractiveness Analysis
    • 9.12.1. By Country
    • 9.12.2. By Product Type
    • 9.12.3. By Drug Class
    • 9.12.4. By Disease Indication
    • 9.12.5. Distribution Channel
  • 9.13. Drivers and Restraints: Impact Analysis
  • 9.14. Key Market Participants - Intensity Mapping
  • 9.15. Key Mergers & Acquisitions

10. Europe Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2017
    • 10.2.1. EU-4
    • 10.2.2. U.K
    • 10.2.3. Benelux
    • 10.2.4. Rest of Western Europe
  • 10.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
  • 10.4. Historical Market Size (US$ Mn) Trend Analysis by Product Type, 2013-2017
    • 10.4.1. Topical
    • 10.4.2. Oral
    • 10.4.3. Injectable
  • 10.5. Market Size (US$ Mn) & Forecast By Product Type, 2018-2028
  • 10.6. Historical Market Size (US$ Mn) Trend Analysis by Drug Class, 2013-2017
    • 10.6.1. Interleukin Inhibitors
    • 10.6.2. Corticosteroids
    • 10.6.3. Anti-inflammatory
    • 10.6.4. Tumor Necrosis Factor Inhibitor
  • 10.7. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
  • 10.8. Historical Market Size (US$ Mn) Trend Analysis by Disease Indication, 2013-2017
    • 10.8.1. Plaque Psoriasis
    • 10.8.2. Nail Psoriasis
    • 10.8.3. Guttate Psoriasis
    • 10.8.4. Pustular Psoriasis
    • 10.8.5. Erythrodermic Psoriasis
  • 10.9. Market Size (US$ Mn) Forecast By End Disease Indication, 2018-2028
  • 10.10. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2017
    • 10.10.1. Hospital Pharmacies
    • 10.10.2. Retail Pharmacies
    • 10.10.3. E-Commerce
  • 10.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018- 2028
  • 10.12. Market Attractiveness Analysis
    • 10.12.1. By Country
    • 10.12.2. By Product Type
    • 10.12.3. By Drug Class
    • 10.12.4. By Disease Indication
    • 10.12.5. Distribution Channel
  • 10.13. Drivers and Restraints: Impact Analysis
  • 10.14. Key Market Participants - Intensity Mapping
  • 10.15. Key Mergers & Acquisitions

12. Asia Pacific Excluding China & Japan Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2017
    • 12.2.1. India
    • 12.2.2. Australia and New Zealand
    • 12.2.3. ASEAN
    • 12.2.4. Rest of APECJ
  • 12.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
  • 12.4. Historical Market Size (US$ Mn) Trend Analysis by Product Type, 2013-2017
    • 12.4.1. Topical
    • 12.4.2. Oral
    • 12.4.3. Injectable
  • 12.5. Market Size (US$ Mn) & Forecast By Product Type, 2018-2028
  • 12.6. Historical Market Size (US$ Mn) Trend Analysis by Drug Class, 2013-2017
    • 12.6.1. Interleukin Inhibitors
    • 12.6.2. Corticosteroids
    • 12.6.3. Anti-inflammatory
    • 12.6.4. Tumor Necrosis Factor Inhibitor
  • 12.7. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
  • 12.8. Historical Market Size (US$ Mn) Trend Analysis by Disease Indication, 2013-2017
    • 12.8.1. Plaque Psoriasis
    • 12.8.2. Nail Psoriasis
    • 12.8.3. Guttate Psoriasis
    • 12.8.4. Pustular Psoriasis
    • 12.8.5. Erythrodermic Psoriasis
  • 12.9. Market Size (US$ Mn) Forecast By End Disease Indication, 2018-2028
  • 12.10. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2017
    • 12.10.1. Hospital Pharmacies
    • 12.10.2. Retail Pharmacies
    • 12.10.3. E-Commerce
  • 12.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
  • 12.12. Market Attractiveness Analysis
    • 12.12.1. By Country
    • 12.12.2. By Product Type
    • 12.12.3. By Drug Class
    • 12.12.4. By Disease Indication
    • 12.12.5. Distribution Channel
  • 12.13. Drivers and Restraints: Impact Analysis
  • 12.14. Key Market Participants - Intensity Mapping
  • 12.15. Key Mergers & Acquisitions

13. CIS & Russia Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis by Product Type, 2013-2017
    • 13.2.1. Topical
    • 13.2.2. Oral
    • 13.2.3. Injectable
  • 13.3. Market Size (US$ Mn) & Forecast By Product Type, 2018-2028
  • 13.4. Historical Market Size (US$ Mn) Trend Analysis by Drug Class, 2013-2017
    • 13.4.1. Interleukin Inhibitors
    • 13.4.2. Corticosteroids
    • 13.4.3. Anti-inflammatory
    • 13.4.4. Tumor Necrosis Factor Inhibitor
  • 13.5. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
  • 13.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Indication, 2013-2017
    • 13.6.1. Plaque Psoriasis
    • 13.6.2. Nail Psoriasis
    • 13.6.3. Guttate Psoriasis
    • 13.6.4. Pustular Psoriasis
    • 13.6.5. Erythrodermic Psoriasis
  • 13.7. Market Size (US$ Mn) Forecast By End Disease Indication, 2018-2028
  • 13.8. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2017
    • 13.8.1. Hospital Pharmacies
    • 13.8.2. Retail Pharmacies
    • 13.8.3. E-Commerce
  • 13.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
  • 13.10. Market Attractiveness Analysis
    • 13.10.1. By Country
    • 13.10.2. By Product Type
    • 13.10.3. By Drug Class
    • 13.10.4. By Disease Indication
    • 13.10.5. Distribution Channel
  • 13.11. Drivers and Restraints: Impact Analysis
  • 13.12. Key Market Participants - Intensity Mapping
  • 13.13. Key Mergers & Acquisitions

14. Japan Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Product Type, 2013-2017
    • 14.2.1. Topical
    • 14.2.2. Oral
    • 14.2.3. Injectable
  • 14.3. Market Size (US$ Mn) & Forecast By Product Type, 2018-2028
  • 14.4. Historical Market Size (US$ Mn) Trend Analysis by Drug Class, 2013-2017
    • 14.4.1. Interleukin Inhibitors
    • 14.4.2. Corticosteroids
    • 14.4.3. Anti-inflammatory
    • 14.4.4. Tumor Necrosis Factor Inhibitor
  • 14.5. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
  • 14.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Indication, 2013-2017
    • 14.6.1. Plaque Psoriasis
    • 14.6.2. Nail Psoriasis
    • 14.6.3. Guttate Psoriasis
    • 14.6.4. Pustular Psoriasis
    • 14.6.5. Erythrodermic Psoriasis
  • 14.7. Market Size (US$ Mn) Forecast By End Disease Indication, 2018-2028
  • 14.8. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2017
    • 14.8.1. Hospital Pharmacies
    • 14.8.2. Retail Pharmacies
    • 14.8.3. E-Commerce
  • 14.9 .Market Size (US$ Mn) Forecast by Distribution Channel, 2018-2028
  • 14.10. Market Attractiveness Analysis
    • 14.10.1. By Country
    • 14.10.2. By Product Type
    • 14.10.3. By Drug Class
    • 14.10.4. By Disease Indication
    • 14.10.5. Distribution Channel
  • 14.11. Drivers and Restraints: Impact Analysis
  • 14.12. Key Market Participants - Intensity Mapping
  • 14.13. Key Mergers & Acquisitions

15. Middle East and Africa Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2017
    • 15.2.1. GCC Countries
    • 15.2.2. South Africa
    • 15.2.3. Rest of Middle East and Africa
  • 15.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
  • 15.4. Historical Market Size (US$ Mn) Trend Analysis by Product Type, 2013-2017
    • 15.4.1. Topical
    • 15.4.2. Oral
    • 15.4.3. Injectable
  • 15.5. Market Size (US$ Mn) & Forecast By Product Type, 2018-2028
  • 15.6. Historical Market Size (US$ Mn) Trend Analysis by Drug Class, 2013-2017
    • 15.6.1. Interleukin Inhibitors
    • 15.6.2. Corticosteroids
    • 15.6.3. Anti-inflammatory
    • 15.6.4. Tumor Necrosis Factor Inhibitor
  • 15.7. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
  • 15.8. Historical Market Size (US$ Mn) Trend Analysis by Disease Indication, 2013-2017
    • 15.8.1. Plaque Psoriasis
    • 15.8.2. Nail Psoriasis
    • 15.8.3. Guttate Psoriasis
    • 15.8.4. Pustular Psoriasis
    • 15.8.5. Erythrodermic Psoriasis
  • 15.9. Market Size (US$ Mn) Forecast By End Disease Indication, 2018-2028
  • 15.10. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2017
    • 15.10.1. Hospital Pharmacies
    • 15.10.2. Retail Pharmacies
    • 15.10.3. E-Commerce
  • 15.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
  • 15.12. Market Attractiveness Analysis
    • 15.12.1. By Country
    • 15.12.2. By Product Type
    • 15.12.3. By Drug Class
    • 15.12.4. By Disease Indication
    • 15.12.5. Distribution Channel
  • 15.13. Drivers and Restraints: Impact Analysis
  • 15.14. Key Market Participants - Intensity Mapping
  • 15.15. Key Mergers & Acquisitions

16. Forecast Factors: Relevance and Impact

17. Forecast Assumptions

18. Market Structure Analysis

  • 18.1. Market Structure by Tier of Companies
  • 18.2. Market Share Analysis % (2017)
  • 18.3. Brand Share Analysis (%), By Key Products

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competitors Deep Dive
    • 19.3.1. Janssen Biotech, Inc.
      • 19.3.1.1. Overview
      • 19.3.1.2. Product and Application Portfolio
      • 19.3.1.3. Production Footprint
      • 19.3.1.4. Sales Footprint
      • 19.3.1.5. Channel Footprint
      • 19.3.1.6. Strategy
        • 19.3.1.6.1.1. Marketing Strategy
        • 19.3.1.6.1.2. Product Strategy
        • 19.3.1.6.1.3. Channel Strategy
    • 19.3.2. Novartis International Ltd.
    • 19.3.3. Amgen Inc.
    • 19.3.4. Pfizer Inc.
    • 19.3.5. Takeda Pharmaceutical Company Ltd.
    • 19.3.6. Merck & Co, Inc.
    • 19.3.7. Abb Vie Inc.
    • 19.3.8. Eli Lilly and Company
    • 19.3.9. Boehringer Ingelheim GmbH
    • 19.3.10. Sun Pharmaceutical Industries Ltd

20. Global Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027 by Region

  • 20.1. Introduction / Key Findings
  • 20.2. Historical Market Size (US$ Mn) Analysis by Region
    • 20.2.1. North America
    • 20.2.2. Latin America
    • 20.2.3. Europe
    • 20.2.4. Asia Pacific Excluding Japan
    • 20.2.5. Japan
    • 20.2.6. CIS & Russia
    • 20.2.7. Middle East and Africa
  • 20.3. Market Size (US$ Mn) Forecast By Region
  • 20.4. Market Attractiveness Analysis by Region

21. Global Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027, By Product Type

  • 21.1. Introduction/Key Finding
  • 21.2. Historical Market Size (US$ Mn) & Analysis by Product Type, 2013-2017
    • 21.2.1. Topical
    • 21.2.2. Oral
    • 21.2.3. Injectable
  • 21.3. Market Size (US$ Mn) & Forecast By Product Type, 2018-2028
  • 21.4. Market Attractiveness Analysis by Product Type

22. Global Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027, By Drug Class

  • 22.1. Introduction/Key Finding
  • 22.2. Historical Market Size (US$ Mn) Analysis by Drug Class, 2013-2017
    • 22.2.1. Interleukin Inhibitors
    • 22.2.2. Corticosteroids
    • 22.2.3. Anti-inflammatory
    • 22.2.4. Tumor Necrosis Factor Inhibitor
  • 22.3. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
  • 22.4. Market Attractiveness Analysis by Drug Class

23. Global Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027, By Disease Indication

  • 23.1. Introduction/Key Finding
  • 23.2. Historical Market Size (US$ Mn) Analysis by Disease Indication, 2013-2017
    • 23.2.1. Plaque Psoriasis
    • 23.2.2. Nail Psoriasis
    • 23.2.3. Guttate Psoriasis
    • 23.2.4. Pustular Psoriasis
    • 23.2.5. Erythrodermic Psoriasis
  • 23.3. Market Size (US$ Mn) Forecast By Disease Indication, 2018-2028
  • 23.4. Market Attractiveness Analysis by Disease Indication

24. Global Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel

  • 24.1. Introduction/Key Finding
  • 24.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2013-2017
    • 24.2.1. Hospital Pharmacies
    • 24.2.2. Retail Pharmacies
    • 24.2.3. E-Commerce
  • 24.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028

Market Attractiveness Analysis by Distribution Channel

25. Global Psoriasis Drug Treatment Market Analysis 2012-2016 and Forecast 2017-2027

  • 25.1. Market Value Share Analysis by All Segment
  • 25.2. Y-o-Y Growth Analysis by All Segment
  • 25.3. Absolute $ Opportunity

26. Assumptions and Acronyms Used

27. Research Methodology

List of Tables

  • Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
  • Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
  • Table 03: CPT Codes for Psoriasis Treatment
  • Table 04: North America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 05: North America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
  • Table 06: North America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 07: North America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 08: North America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 09: Latin America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 10: Latin America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
  • Table 11: Latin America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 12: Latin America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 13: Latin America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 14: Europe Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 15: Europe Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
  • Table 16: Europe Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 17: Europe Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 18: Europe Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 19: CIS & Russia Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
  • Table 20: CIS & Russia Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 21: CIS & Russia Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 22: CIS & Russia Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 23: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 24: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
  • Table 25: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 26: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 27: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 28: Japan Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
  • Table 29: Japan Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 30: Japan Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 31: Japan Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 32: Middle Eastern Africa Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
  • Table 33: Middle Eastern Africa Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
  • Table 34: Middle Eastern Africa Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 35: Middle Eastern Africa Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application
  • Table 36: Middle Eastern Africa Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 37: Global Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Region
  • Table 38: Global Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
  • Table 39: Global Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
  • Table 40: Global Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
  • Table 41: Global Psoriasis Drug Treatments Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

List of Figures

  • Figure 01: Psoriasis Drug Treatments Market Value Share by Region (2018)
  • Figure 02: Global Healthcare Expenditure in US$ Tn (2013-2020)
  • Figure 03: North America Psoriasis Drug Treatments Market Value Share (2017A), By Country
  • Figure 04: North America Psoriasis Drug Treatments Market Value Share (2017A), By Product Type, Drug Class and Distribution channel
  • Figure 05: North America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 06: North America Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 07: North America Psoriasis Drug Treatments Market Y-o-Y growth (%) Comparison, By Country, 2018-2028
  • Figure 08: U.S. Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 09: U.S. Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 10: Canada Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 11: Canada Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 12: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Topical
  • Figure 13: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Topical
  • Figure 14: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Oral
  • Figure 15: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by oral
  • Figure 16: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Injectable
  • Figure 17: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Injectable
  • Figure 18: North America Psoriasis Drug Treatments Market Attractiveness Analysis, By Product Type
  • Figure 19: North America Psoriasis Drug Treatments Market Attractiveness Analysis, By Drug Class
  • Figure 20: North America Psoriasis Drug Treatments Market Attractiveness Analysis, By Disease Indication
  • Figure 21: North America Psoriasis Drug Treatments Market Attractiveness Analysis, By Country
  • Figure 22: North America Psoriasis Drug Treatments Market Attractiveness Analysis, By Distribution Channel
  • Figure 23: Latin America Psoriasis Drug Treatments Market Value Share (2017A), By Country
  • Figure 24: Latin America Psoriasis Drug Treatments Market Value Share (2017A), By Product Type, Drug Class and Distribution channel
  • Figure 25: Latin America Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 26: Latin America Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 27: Latin America Psoriasis Drug Treatments Market Y-o-Y growth (%) Comparison, By Country, 2018-2028
  • Figure 28: Brazil. Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 29: Brazil Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 30: Mexico Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 31: Mexico Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 32: Rest of LA Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 33: Rest of LA Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 34: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Topical
  • Figure 35: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Topical
  • Figure 36: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Oral
  • Figure 37: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Oral
  • Figure 38: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Injectable
  • Figure 39: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Injectable
  • Figure 40: Latin America Psoriasis Drug Treatments Market Attractiveness Analysis, By Product Type
  • Figure 41: Latin America Psoriasis Drug Treatments Market Attractiveness Analysis, By Drug Class
  • Figure 42: Latin America Psoriasis Drug Treatments Market Attractiveness Analysis, By Disease Indication
  • Figure 43: Latin America Psoriasis Drug Treatments Market Attractiveness Analysis, By Country
  • Figure 44: Latin America Psoriasis Drug Treatments Market Attractiveness Analysis, By Distribution Channel
  • Figure 45: Europe Psoriasis Drug Treatments Market Value Share (2017A), By Country
  • Figure 46: Europe Psoriasis Drug Treatments Market Value Share (2017A), By Product Type, Drug Class and Distribution channel
  • Figure 47: Europe Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 48: Europe Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 49: Europe Psoriasis Drug Treatments Market Y-o-Y growth (%) Comparison, By Country, 2018-2028
  • Figure 50: EU 4. Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 51: EU 4 Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 52: UK Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 53: UK Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 54: BENELUX. Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 55: BENELUX Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 56: Rest of Europe Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 57: Rest of Europe Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 58: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Topical
  • Figure 59: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Topical
  • Figure 60: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Oral
  • Figure 61: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Oral
  • Figure 62: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Injectable
  • Figure 63: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Injectable
  • Figure 64: Europe Psoriasis Drug Treatments Market Attractiveness Analysis, By Product Type
  • Figure 65: Europe Psoriasis Drug Treatments Market Attractiveness Analysis, By Drug Class
  • Figure 66: Europe Psoriasis Drug Treatments Market Attractiveness Analysis, By Disease Indication
  • Figure 67: Europe Psoriasis Drug Treatments Market Attractiveness Analysis, By Country
  • Figure 68: Europe Psoriasis Drug Treatments Market Attractiveness Analysis, By Distribution Channel
  • Figure 69: CIS & Russia Market Value Share (2017A), By Product Type, Drug Class, and Distribution Channel
  • Figure 70: CIS & Russia Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 71: CIS & Russia Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 72: CIS & Russia Psoriasis Drug Treatments Market Y-o-Y growth (%) Comparison, By Country, 2018-2028
  • Figure 73: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Topical
  • Figure 74: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Topical
  • Figure 75: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Oral
  • Figure 76: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Oral
  • Figure 77: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Injectable
  • Figure 78: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Injectable
  • Figure 79: CIS & Russia Psoriasis Drug Treatments Market Attractiveness Analysis, By Product Type
  • Figure 80: CIS & Russia Psoriasis Drug Treatments Market Attractiveness Analysis, By Disease Indication
  • Figure 81: CIS & Russia Psoriasis Drug Treatments Market Attractiveness Analysis, By Drug Class
  • Figure 82: CIS & Russia Psoriasis Drug Treatments Market Attractiveness Analysis, By Distribution Channel
  • Figure 83: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Value Share (2017A), By Country
  • Figure 84: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Value Share (2017A), By Product Type, Drug Class and Distribution channel
  • Figure 85: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 86: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 87: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Y-o-Y growth (%) Comparison, By Country, 2018-2028
  • Figure 88: Greater China Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 89: Greater China Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 90: India Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 91: India Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 92: ASEAN Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 93: ASEAN Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 94: South Korea Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 95: South Korea Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 96: Rest of APEJ Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 97: Rest of APEJ Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 98: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Topical
  • Figure 99: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Topical
  • Figure 100: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Oral
  • Figure 101: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Oral
  • Figure 102: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Injectable
  • Figure 103: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Injectable
  • Figure 104: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Attractiveness Analysis, By Product Type
  • Figure 105: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Attractiveness Analysis, By Drug Class
  • Figure 106: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Attractiveness Analysis, By Disease Indication
  • Figure 107: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Attractiveness Analysis, By Country
  • Figure 108: Asia Pacific ex. Japan Psoriasis Drug Treatments Market Attractiveness Analysis, By Distribution Channel
  • Figure 109: Japan Market Value Share (2017A), By Product Type, Drug Class, and Distribution Channel
  • Figure 110: Japan Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 111: Japan Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 112: Japan Psoriasis Drug Treatments Market Y-o-Y growth (%) Comparison, By Country, 2018-2028
  • Figure 113: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Topical
  • Figure 114: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Topical
  • Figure 115: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Oral
  • Figure 116: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Oral
  • Figure 117: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Injectable
  • Figure 118: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Injectable
  • Figure 119: Japan Psoriasis Drug Treatments Market Attractiveness Analysis, By Product Type
  • Figure 120: Japan Psoriasis Drug Treatments Market Attractiveness Analysis, By Disease Indication
  • Figure 121: Japan Psoriasis Drug Treatments Market Attractiveness Analysis, By Drug Class
  • Figure 122: Japan Psoriasis Drug Treatments Market Attractiveness Analysis, By Distribution Channel
  • Figure 123: Middle Eastern Africa Psoriasis Drug Treatments Market Value Share (2017A), By Country
  • Figure 124: Middle Eastern Africa Psoriasis Drug Treatments Market Value Share (2017A), By Product Type, Drug Class and Distribution channel
  • Figure 125: Middle Eastern Africa Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 126: Middle Eastern Africa Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 127: Middle Eastern Africa Psoriasis Drug Treatments Market Y-o-Y growth (%) Comparison, By Country, 2018-2028
  • Figure 128: GCC Countries Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 129: GCC Countries Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 130: South Africa Psoriasis Drug Treatments Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028
  • Figure 131: South Africa Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 132: Rest of MEA Psoriasis Drug Treatments Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 133: Rest of MEA Psoriasis Drug Treatments Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028
  • Figure 134: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Topical
  • Figure 135: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Topical
  • Figure 136: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Oral
  • Figure 137: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Oral
  • Figure 138: Psoriasis Drug Treatment Market Size (US$ Mn) Analysis, 2013-2017, by Injectable
  • Figure 139: Psoriasis Drug Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028, by Injectable
  • Figure 140: Middle Eastern Africa Psoriasis Drug Treatments Market Attractiveness Analysis, By Product Type
  • Figure 141: Middle Eastern Africa Psoriasis Drug Treatments Market Attractiveness Analysis, By Drug Class
  • Figure 142: Middle Eastern Africa Psoriasis Drug Treatments Market Attractiveness Analysis, By Disease Indication
  • Figure 143: Middle Eastern Africa Psoriasis Drug Treatments Market Attractiveness Analysis, By Country
  • Figure 144: Middle Eastern Africa Psoriasis Drug Treatments Market Attractiveness Analysis, By Distribution Channel
  • Figure 145: Global Psoriasis Drug Treatments Market Attractiveness Analysis, By Product Type
  • Figure 146: Global Psoriasis Drug Treatments Market Attractiveness Analysis, By Region
  • Figure 146: Global Psoriasis Drug Treatments Market Attractiveness Analysis, By Distribution Channel
  • Figure 147: Global Psoriasis Drug Treatments Market Attractiveness Analysis, By Disease Indication
  • Figure 148: Global Psoriasis Drug Treatments Market Attractiveness Analysis, By Drug Class
  • Figure 148: Global Psoriasis Drug Treatments Market Size and Y-o-Y, 2013 - 2017
  • Figure 149: Global Psoriasis Drug Treatments Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2028
  • Figure 150: Global Psoriasis Drug Treatments Market Absolute $ Opportunity, 2013-2028
Back to Top